Document:

Predictmedix Inc.: Exhibit 4.11 - Filed by newsfilecorp.com

    

    ASSIGNMENT OF PATENT RIGHTS

    WHEREAS, I, Rajiv Muradia, of 111 Echo Drive, Unit 8, Ottawa, Ontario K1S 5K8, Canada, and Rahul Kushwah, of 141 Codsell Avenue, Toronto M3H 3W5, Canada, Sheldon Kales, made certain new and useful inventions and improvements for which application for United States Letters Patent application, entitled "SYSTEM AND METHOD TO PROVIDE PRODUCT RECOMMENDATION AND SPONSORED CONTENT TO PATIENTS MANAGED BY COMPUTERIZED WORKFLOWS FOR TREATMENT PROTOCOLS" filed on August 6, 2021;

    AND WHEREAS, PredictMedix, Inc., a corporation organized and existing under and by virtue of the laws of the Country of Canada, and having an office and place of business at 77 King Street West, Suite 3000, Toronto M5K 1G8, Canada, (hereinafter "Assignee"), is desirous of acquiring the entire right, title and interest in and to said inventions, improvements, applications, and in and to any Letters Patent to be obtained therefore;

    NOW, THEREFORE, to all whom it may concern, be it known that for good and valuable consideration, the receipt and sufficiency whereof is hereby acknowledged, I have sold, assigned, and transferred, and by these presents do sell, assign, and transfer unto said Assignee, its successors or assigns, the entire right, title and interest for all countries in and to all inventions and improvements disclosed in the aforesaid application, and in and to said application, all divisions, continuations, continuations-in-part, or renewals thereof, all Letters Patent which may be granted there from, and all reissues or extensions of such patents, and in and to any and all applications which have been or shall be filed in any foreign countries for Letters Patent for said inventions and improvements, including an assignment of all rights under the provisions of the International Convention, and all Letters Patent of foreign countries which may be granted there from; and I do hereby authorize and request the Commissioner of Patents and Trademarks to issue any and all United States Letters Patent for the aforesaid inventions and improvements to the said Assignee as the assignee of the entire right, title and interest in and to the same, for the use of the said Assignee, its successors and assigns.

    

    AND, for the aforementioned consideration, I do hereby agree that I and my executors and legal representatives will make, execute, and deliver any and all other instruments in writing including any and all further application papers, affidavits, assignments, and other documents, and will communicate to said Assignee, its successors and representatives all facts known to us relating to said improvements and the history thereof and will testify in all legal proceedings and generally do all things which may be necessary or desirable more effectually to secure to and vest in said Assignee, its successors or assigns the entire right, title and interest in and to the said improvements, inventions, applications, Letters Patent, rights, titles, benefits, privileges and advantages hereby sold, assigned and conveyed, or intended so to be.

    AND, furthermore, I covenant and agree with said Assignee, its successors and assigns, that I have made no assignment, grant, mortgage, license, or other agreement affecting the rights and property herein conveyed to any other parties, and that I possess the full right to convey the same as expressed herein.

    Effective as of the 6th day of August, 2021. 

    	 	By:  		    
	 	      Rajiv Muradia	 
	 	 	 	 
	 	By:		 
	 	      Rahul KushwahPredictmedix Inc.: Exhibit 4.12 - Filed by newsfilecorp.com

    

    ASSIGNMENT OF PATENT RIGHTS

    WHEREAS, I, Rajiv Muradia, of 111 Echo Drive, Unit 8, Ottawa, Ontario K1S 5K8, Canada, and Rahul Kushwah, of 141 Codsell Avenue, Toronto M3H 3W5, Canada, Sheldon Kales, made certain new and useful inventions and improvements for which application for United States Letters Patent application, entitled "UTILIZING HEALTHCARE PROVIDERS NETWORK EFFECT TO INCREASE COMPLIANCE FOR BETTER HEALTH OUTCOMES";

    AND WHEREAS, PredictMedix, Inc., a corporation organized and existing under and by virtue of the laws of the Country of Canada, and having an office and place of business at 77 King Street West, Suite 3000, Toronto M5K 1G8, Canada, (hereinafter "Assignee"), is desirous of acquiring the entire right, title and interest in and to said inventions, improvements, applications, and in and to any Letters Patent to be obtained therefore;

    NOW, THEREFORE, to all whom it may concern, be it known that for good and valuable consideration, the receipt and sufficiency whereof is hereby acknowledged, I have sold, assigned, and transferred, and by these presents do sell, assign, and transfer unto said Assignee, its successors or assigns, the entire right, title and interest for all countries in and to all inventions and improvements disclosed in the aforesaid application, and in and to said application, all divisions, continuations, continuations-in-part, or renewals thereof, all Letters Patent which may be granted there from, and all reissues or extensions of such patents, and in and to any and all applications which have been or shall be filed in any foreign countries for Letters Patent for said inventions and improvements, including an assignment of all rights under the provisions of the International Convention, and all Letters Patent of foreign countries which may be granted there from; and I do hereby authorize and request the Commissioner of Patents and Trademarks to issue any and all United States Letters Patent for the aforesaid inventions and improvements to the said Assignee as the assignee of the entire right, title and interest in and to the same, for the use of the said Assignee, its successors and assigns.

    

    AND, for the aforementioned consideration, I do hereby agree that I and my executors and legal representatives will make, execute, and deliver any and all other instruments in writing including any and all further application papers, affidavits, assignments, and other documents, and will communicate to said Assignee, its successors and representatives all facts known to us relating to said improvements and the history thereof and will testify in all legal proceedings and generally do all things which may be necessary or desirable more effectually to secure to and vest in said Assignee, its successors or assigns the entire right, title and interest in and to the said improvements, inventions, applications, Letters Patent, rights, titles, benefits, privileges and advantages hereby sold, assigned and conveyed, or intended so to be.

    AND, furthermore, I covenant and agree with said Assignee, its successors and assigns, that I have made no assignment, grant, mortgage, license, or other agreement affecting the rights and property herein conveyed to any other parties, and that I possess the full right to convey the same as expressed herein.

    Effective as of the 28th day of July, 2021.

    	 	By:  		    
	 	      Rajiv Muradia	 
	 	 	 	 
	 	By:		 
	 	      Rahul KushwahExhibit 10.2

 

FORM OF

FIRST AMENDMENT TO LOCK-UP
AGREEMENT

 

This
First Amendment To Lock-Up/Leak Out Agreement, dated as of October 1, 2021 (this “Agreement”) and effective as of October
1, 2021 (the “Effective Date”), amends that certain Lock-Up/Leak Out Agreement made and entered into as of February
26, 2021 (the “Lock-Up”), by and between Marijuana Company of America, Inc., a Utah corporation (“MCOA”)
and Eco Innovation Group, Inc., a Nevada corporation (“ECOX”).

 

WHEREAS,
MCOA and ECOX desire to amend the Lock-Up on the terms and conditions set forth below.

 

NOW,
THEREFORE, in consideration of the premises and the mutual covenants, agreements, and considerations herein contained, and other good
and valuable consideration, which consideration the parties hereby acknowledge and confirm the receipt and sufficiency thereof, the parties
hereto agree as follows:

 

1.                 
Amendment to Lock-Up.

 

(a)       Effective
as of the Effective Date, Section 1.(a) of the Lock-Up is hereby amended and restated to provide as follows:

 

“SECTION
1. (a) The resale of the Shares and Exchange Shares shall be according to the following schedule: Beginning on the Closing Date and for
six (6) months thereafter, the parties may not sell any Shares or Exchange Shares (the “Initial Lock-Up Period”) and thereafter
shall be limited to sell not more than the quantity of shares equaling an aggregate maximum sale value of $20,000 per week, or $80,000
per month until all Shares and Exchange Shares are sold.”

 

2.                 Consideration.
Each of the parties agrees and confirms by signing below that they have received valid consideration in connection with this Agreement
and the transactions contemplated herein.

 

3.                 Mutual
Representations, Covenants and Warranties. Each of the parties, for themselves and for the benefit
of each of the other parties hereto, represents, covenants and warranties that (a) such party has all requisite power and authority, corporate
or otherwise, to execute and deliver this Agreement and to consummate the transactions contemplated hereby and thereby and this Agreement
constitutes the legal, valid and binding obligation of such party enforceable against such party in accordance with its terms, except
as such enforcement may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’
rights generally and general equitable principles;  (b) the execution and delivery by such party and the consummation of the transactions
contemplated hereby and thereby do not and shall not, by the lapse of time, the giving of notice or otherwise: (i) constitute a violation
of any law; or (ii) constitute a breach of any provision contained in, or a default under, any governmental approval, any writ, injunction,
order, judgment or decree of any governmental authority or any contract to which such party is bound or affected; and (c) any individual
executing this Agreement on behalf of an entity has authority to act on behalf of such entity and has been duly and properly authorized
to sign this Agreement on behalf of such entity.

 

4.                 Further
Assurances. The parties agree that, from time to time, each of them will take such other action
and to execute, acknowledge and deliver such contracts, deeds, or other documents as may be reasonably requested and necessary or appropriate
to carry out the purposes and intent of this Agreement and the transactions contemplated herein.

 

5.                 Effect
of Agreement. Upon the effectiveness of this Agreement, each reference in the Lock-Up to “Agreement,”
“hereunder,” “hereof,” “herein” or words of like import shall mean and be a reference to such Lock-Up
as modified or amended hereby.

 

6.                 Lock-Up
to Continue in Full Force and Effect. Except as specifically modified or amended herein, the
Lock-Up and the terms and conditions thereof shall remain in full force and effect.

 

 

    	  

    	 

    

 

7.                 Entire
Agreement. This Agreement sets forth all of the promises, agreements, conditions, understandings,
warranties and representations among the parties with respect to the transactions contemplated hereby and thereby, and supersedes all
prior agreements, arrangements and understandings between the parties, whether written, oral or otherwise.

 

8.                 Construction.
In this Agreement words importing the singular number include the plural and vice versa; words importing the masculine gender include
the feminine and neuter genders.

 

9.                 Heirs,
Successors and Assigns. Each and all of the covenants, terms, provisions and agreements herein
contained shall be binding upon and inure to the benefit of the parties hereto and their respective heirs, legal representatives, successors
and assigns.

 

10.             
Counterparts and Signatures. This Agreement and any signed
agreement or instrument entered into in connection with this Agreement, and any amendments hereto or thereto, may be executed in one or
more counterparts, all of which shall constitute one and the same instrument. Any such counterpart, to the extent delivered by means of
a facsimile machine or by .pdf, .tif, .gif, .jpeg or similar attachment to electronic mail (any such delivery, an “Electronic
Delivery”) shall be treated in all manner and respects as an original executed counterpart and shall be considered to have the
same binding legal effect as if it were the original signed version thereof delivered in person. No party shall raise the use of Electronic
Delivery to deliver a signature or the fact that any signature or agreement or instrument was transmitted or communicated through the
use of Electronic Delivery as a defense to the formation of a contract, and each such party forever waives any such defense, except to
the extent such defense relates to lack of authenticity.

  

IN WITNESS WHEREOF, parties
have caused this Agreement to be signed and delivered by their duly authorized representatives as of the date first set forth above to
be effective as of the Effective Date.

 

	MARIJUANA COMPANY OF AMERICA, INC.
	 	 
	By:	 	/s/ Jesus Quintero
	Name:	 	Jesus Quintero
	Title:	 	Chief Executive Officer
	 
	ECO INNOVATION GROUP, INC.
	 	 
	By:	 	/s/ Julia Otey-Raudes
	Name:	 	Julia Otey-Raudes
	Title:	 	Chief Executive Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}]]